EN
Back to the archive

The archive · Health & Care · Product decision · 2019–2025

Ultrahuman bets a no-subscription smart ring can unseat Oura; $35M raised, FY25 profit

Ultrahuman bet no-subscription smart rings plus a CGM ecosystem could overtake Oura; FY25 revenue 5x'd to ₹565 Cr, first profit.

Ultrahuman

The betThat consumers would choose a subscription-free ring over Oura and keep buying CGMs and blood tests, turning one device into a multi-device health platform.Scaling

What the business is

Metabolic health wearables: the Ring Air smart ring, M1 continuous glucose monitor, at-home blood testing (Blood Vision) and a home health sensor.

Starting capital$17.5M (Aug 2021) + $35M Series B (Mar 2024) + ₹100 Cr venture debt (Nov 2025)

How it started

Founded in 2019 in Bengaluru by ex-Zomato executives Mohit Kumar and Vatsal Singhal, who had sold their logistics startup Runnr to Zomato. They began with continuous glucose monitoring, launched their first smart ring in July 2022 and the slimmer Ring Air in June 2023.

What happened

Raised $17.5M in Aug 2021 and $35M in Mar 2024 from Blume, Steadview, Nexus, Alpha Wave and Zomato founder Deepinder Goyal. Expanded to 100+ markets, opened an 'UltraFactory' sized for $200M annual revenue and claimed company-level profitability; a metabolic-scoring study it ran appeared in Nature. In 2025 the US ITC found Ring Air infringed an Oura patent, threatening a US import ban from Oct 21; Ultrahuman redesigned the ring and resumed shipping.

How it ended up

FY25 (ended Mar 2025) revenue rose ~5x to ₹564.7 Cr with a first net profit of ₹71.5 Cr; Ring Air alone did ₹516 Cr. In Nov 2025 it raised ₹100 Cr in venture debt and was targeting a $100M+ equity round, still racing Oura with a redesigned US product.

Background

Bengaluru's Ultrahuman was founded in 2019 by Mohit Kumar and Vatsal Singhal, two ex-Zomato operators who had already sold a logistics startup (Runnr) to Zomato. Their original product was metabolic health: a continuous glucose monitor (CGM) service that showed users how food and lifestyle moved their blood sugar. The company then extended the same 'quantify your body' thesis into a smart ring, launching the first Ultrahuman Ring in July 2022 and the slimmer Ring Air in June 2023.

The strategic bet was explicitly anti-Oura. Oura, the category leader, locked tracking insights behind a paid membership; Ultrahuman sold its ring outright with no subscription, priced it as a single purchase, and pushed into over 100 markets including Asia and the Nordics where no smart-ring leader existed. The ring was designed as a funnel, not a one-off: 20% of ring buyers also bought CGMs (up from 4% a year earlier), and the company added at-home blood testing (Blood Vision) and a home health sensor to feed the same app.

The model held up financially. In March 2024, with roughly $35M ARR and company-level profitability, Ultrahuman raised a $35M Series B from Blume, Steadview, Nexus, Alpha Wave and Zomato's Deepinder Goyal. In FY25 (ended March 2025), revenue jumped about 5x to ₹564.7 Cr with a first full-year net profit of ₹71.5 Cr, powered by ₹516 Cr in smart-ring sales — roughly ₹344 Cr of it from the US.

The biggest threat came from the incumbent it was chasing. The US International Trade Commission ruled that Ring Air infringed an Oura patent, putting a possible US import ban on the product from October 2025. Ultrahuman redesigned the ring, started production of the new model on September 10, 2025, and kept selling. In November 2025 it raised ₹100 Cr in venture debt from Alteria Capital while targeting a $100M+ equity round.

What has to be true

  • Free tracking on the ring differentiated against Oura's paid membership at a moment of subscription fatigue.
  • Ring-to-CGM cross-sell jumped from 4% to ~20% of users, validating the multi-device funnel thesis.
  • Reaching profitability before raising growth capital let Ultrahuman scale on its own terms.
  • FY25's first profit on 5x revenue showed the model could compound, not just grow.

What can be applied

A subscription-free hardware wedge can beat a subscription incumbent if the device funnels users into higher-margin services — but patents make global expansion a legal fight, not just a sales one.

Aftermath

As of Nov 19, 2025, Ultrahuman was scaling: ₹100 Cr in venture debt from Alteria Capital, a $100M+ equity round in the works, and a redesigned Ring Air shipping again in the US after the ITC patent ruling. FY25 revenue was ₹564.7 Cr with a ₹71.5 Cr profit; the US drove most sales while India revenue actually fell 3% to ₹15.1 Cr. The company remains the second global smart-ring brand behind Oura, with expansion focused on the US, UK and Middle East.

Sources

spotted an error? The archive wants to know.

Your turn

You just read one. Describe what you are building, and see who is betting on the same thing.

Free account · 3 free questions · no card

Related cases